Suivre
Abonner Merck & Co. Inc.

Merck & Co. Inc.

Filtre
  • 02.09.2008 – 19:30

    New Survey Among European Cardiologists Points to a Gap in Cardiovascular Disease Management

    Munich, Germany (ots/PRNewswire) - - In spite of the success of therapies targeting LDL in lowering cardiovascular risk, a residual risk still remains Cardiologists in Europe agree that reducing LDL-cholesterol (LDL-C or "bad" cholesterol) levels is the most important factor in treating dyslipidemia (abnormal blood lipids) and reducing the risk of a ...